CRSP
CRISPR Therapeutics AG (CRSP) Earnings
Review CRISPR Therapeutics AG (CRSP) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- -6.47
- Trailing EPS
- -4.76
- Annual revenue
- $3.51M
- Trailing revenue
- $13.39M
- Next earnings date
- 2026-08-14
CRISPR Therapeutics AG (CRSP) Earnings research
The CRSP earnings page organizes the available earnings-per-share and revenue context for CRISPR Therapeutics AG. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.